Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Japanese Alzheimer's Disease Registry for Disease-Modifying Therapies
jRCT1031240535Recruiting
- Sponsor
- Eisai Co., Ltd.
- Start
- Dec 2024
- Countries
- 1
01
Overview
Open-label, single-arm trial in Alzheimer's disease (AD), sponsored by Eisai Co., Ltd. Primary endpoint: Relationship between ARIA-E/ARIA-H and APOE genotype. Started Dec 2024; status: recruiting.
02
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on jRCT1031240535.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1031240535.